These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6487472)

  • 41. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 42. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.
    Lennard MS; Tucker GT; Woods HF
    Clin Pharmacokinet; 1986; 11(1):1-17. PubMed ID: 2868819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of atenolol and nifedipine on digoxin-induced inotropism in humans.
    Hansen PB; Buch J; Rasmussen OO; Waldorff S; Steiness E
    Br J Clin Pharmacol; 1984 Dec; 18(6):817-22. PubMed ID: 6529522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of atenolol and metoprolol on the anticoagulant activity of acenocoumarin.
    Mantero F; Procidano M; Vicariotto MA; Girolami A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):94S-96S. PubMed ID: 6743479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clearance-based oral drug interaction between verapamil and metoprolol and comparison with atenolol.
    McLean AJ; Knight R; Harrison PM; Harper RW
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1628-9. PubMed ID: 4003307
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of ageing on the disposition of nifedipine and atenolol.
    Scott M; Castleden CM; Adam HK; Smith RP; Fitzsimons TJ
    Br J Clin Pharmacol; 1988 Mar; 25(3):289-96. PubMed ID: 3358894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.
    Bax ND; Lennard MS; Tucker GT; Woods HF; Porter NR; Malia RG; Preston FE
    Br J Clin Pharmacol; 1984 May; 17(5):553-7. PubMed ID: 6329253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transplacental passage of atenolol in man.
    Melander A; Niklasson B; Ingemarsson I; Liedholm H; Scherstén B; Sjöberg NO
    Eur J Clin Pharmacol; 1978 Nov; 14(2):93-4. PubMed ID: 720380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.
    Thomas SH
    Eur J Clin Pharmacol; 1991; 41(3):201-6. PubMed ID: 1748136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
    Feely J
    Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
    [No Abstract]   [Full Text] [Related]  

  • 53. Beta-adrenoceptor blockers and the blood-brian barrier.
    Neil-Dwyer G; Bartlett J; McAinsh J; Cruickshank JM
    Br J Clin Pharmacol; 1981 Jun; 11(6):549-53. PubMed ID: 6115665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).
    Erikssen J; Thaulow E; Mundal R; Opstad P; Nitter-Hauge S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):201S-209S. PubMed ID: 6125171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic interactions of nifedipine and quinidine.
    Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
    Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of rifampicin on metoprolol and antipyrine kinetics.
    Bennett PN; John VA; Whitmarsh VB
    Br J Clin Pharmacol; 1982 Mar; 13(3):387-91. PubMed ID: 7059439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
    Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
    Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics, pharmacology of atenolol and effect of renal disease.
    Wan SH; Koda RT; Maronde RF
    Br J Clin Pharmacol; 1979 Jun; 7(6):569-74. PubMed ID: 465278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.